The role of PML in the nervous system

Molecular Neurobiology

Volumn 43, Issue 2, 2011, Pages 114-123

  Salomoni, Paolo ^a   Betts Henderson, Joanne ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CNS; Neural stem cell; Neurodegeneration; PML; PML nuclear body

Indexed keywords

PROMYELOCYTIC LEUKEMIA PROTEIN;

CELL CYCLE; CELL DEATH; CELL MATURATION; DNA DAMAGE; HUMAN; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NERVOUS SYSTEM; NEURAL STEM CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; REVIEW;

EID: 79958706507     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-010-8156-y     Document Type: Review

References (112)

1. Grimwade D, Solomon E (1997) Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia. Curr Top Microbiol Immunol 220:81-112 (Pubitemid 27141598)
2. Melnick A, Fruchtman S, Zelent A, Liu M, Huang Q, Boczkowska B et al (1999) Identification of novel chromosomal rearrangements in acute myelogenous leukemia involving loci on chromosome 2p23, 15q22 and 17q21. Leukemia 13:1534-1538 (Pubitemid 29465615)
3. Melnick A, Licht JD (1999) Deconstructing a disease: RAR-alpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93:3167-3215 (Pubitemid 29220886)
4. Salomoni P, Pandolfi PP (2002) The role of PML in tumor suppression. Cell 108:165-170 (Pubitemid 34161137)
5. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L et al (2001) The tripartite motif family identifies cell compartments. EMBO J 20:2140-2151 (Pubitemid 32410584)
6. Deshaies RJ, Joazeiro CA (2009) RING domain E3 ubiquitin ligases. Annu Rev Biochem 78:399-434
7. Meroni G, Diez-Roux G (2005) TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. Bioessays 27:1147-1157 (Pubitemid 43076141)
8. Burkhard P, Stetefeld J, Strelkov SV (2001) Coiled coils: a highly versatile protein folding motif. Trends Cell Biol 11:82-88 (Pubitemid 32144755)
9. Borden KL, Boddy MN, Lally J, O'Reilly NJ, Martin S, Howe K et al (1995) The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J 14:1532-1541
10. Borden KL, Lally JM, Martin SR, O'Reilly NJ, Solomon E, Freemont PS (1996) In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML. Proc Natl Acad Sci USA 93:1601-1606 (Pubitemid 26075172)
11. Fagioli M, Alcalay M, Tomassoni L, Ferrucci PF, Mencarelli A, Riganelli D et al (1998) Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival. Oncogene 16:2905-2913 (Pubitemid 28383275)
12. Condemine W, Takahashi Y, Zhu J, Puvion-Dutilleul F, Guegan S, Janin A et al (2006) Characterization of endogenous human promyelocytic leukemia isoforms. Cancer Res 66:6192-6198
13. Fagioli M, Alcalay M, Pandolfi PP, Venturini L, Mencarelli A, Simeone A et al (1992) Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene 7:1083-1091
14. Jensen K, Shiels C, Freemont PS (2001) PML protein isoforms and the RBCC/TRIM motif. Oncogene 20:7223-7233 (Pubitemid 33105011)
15. Nisole S, Stoye JP, Saib A (2005) TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 3:799-808 (Pubitemid 41518740)
16. Lin HK, Bergmann S, Pandolfi PP (2004) Cytoplasmic PML function in TGF-beta signalling. Nature 431:205-211 (Pubitemid 39243475)
17. Salomoni P, Bellodi C (2007) New insights into the cytoplasmic function of PML. Histol Histopathol 22:937-946 (Pubitemid 47034159)
18. Condemine W, Takahashi Y, Le Bras M, de The H (2007) A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells. J Cell Sci 120:3219-3227 (Pubitemid 350018413)
19. Bischof O, Kirsh O, Pearson M, Itahana K, Pelicci PG, Dejean A (2002) Deconstructing PML-induced premature senescence. EMBO J 21:3358-3369 (Pubitemid 34760568)
20. Guo A, Salomoni P, Luo J, Shih A, Zhong S, Gu W et al (2000) The function of PML in p53-dependent apoptosis. Nat Cell Biol 2:730-736
21. Borden KL (2002) Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol Cell Biol 22:5259-5269 (Pubitemid 34755740)
22. Chang KS, Fan YH, Andreeff M, Liu J, Mu ZM (1995) The PML gene encodes a phosphoprotein associated with the nuclear matrix. Blood 85:3646-3653
23. Duprez E, Saurin AJ, Desterro JM, Lallemand-Breitenbach V, Howe K, Boddy MN et al (1999) SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J Cell Sci 112(Pt 3):381-393 (Pubitemid 29080660)
24. Bernardi R, Scaglioni PP, Bergmann S, Horn HF, Vousden KH, Pandolfi PP (2004) PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nat Cell Biol 6:665-672 (Pubitemid 38960925)
25. Yang S, Kuo C, Bisi JE, Kim MK (2002) PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2. Nat Cell Biol 4:865-870 (Pubitemid 35331361)
26. Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T et al (1999) PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol 147:221-234
27. Zhong S, Salomoni P, Pandolfi PP (2000) The transcriptional role of PML and the nuclear body. Nat Cell Biol 2:E85-E90
28. Stuurman N, de Graaf A, Floore A, Josso A, Humbel B, de Jong L et al (1992) A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J Cell Sci 101(Pt 4):773-784
29. Dellaire G, Bazett-Jones DP (2004) PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 26:963-977 (Pubitemid 39273070)
30. Boisvert FM, Hendzel MJ, Bazett-Jones DP (2000) Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J Cell Biol 148:283-292 (Pubitemid 30078240)
31. Eskiw CH, Dellaire G, Bazett-Jones DP (2004) Chromatin contributes to structural integrity of promyelocytic leukemia bodies through a SUMO-1-independent mechanism. J Biol Chem 279:9577-9585 (Pubitemid 38296026)
32. Wang J, Shiels C, Sasieni P, Wu PJ, Islam SA, Freemont PS et al (2004) Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions. J Cell Biol 164:515-526 (Pubitemid 38233313)
33. Kumar PP, Bischof O, Purbey PK, Notani D, Urlaub H, Dejean A et al (2007) Functional interaction between PML and SATB1 regulates chromatin-loop architecture and transcription of the MHC class I locus. Nat Cell Biol 9:45-56 (Pubitemid 46024196)
34. Shiels C, Islam SA, Vatcheva R, Sasieni P, Sternberg MJ, Freemont PS et al (2001) PML bodies associate specifically with the MHC gene cluster in interphase nuclei. J Cell Sci 114:3705-3716 (Pubitemid 33041052)
35. Ayaydin F, Dasso M (2004) Distinct in vivo dynamics of vertebrate SUMO paralogues. Mol Biol Cell 15:5208-5218 (Pubitemid 39564718)
36. Fu C, Ahmed K, Ding H, Ding X, Lan J, Yang Z et al (2005) Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Oncogene 24:5401-5413 (Pubitemid 43080084)
37. Kamitani T, Nguyen HP, Kito K, Fukuda-Kamitani T, Yeh ET (1998) Covalent modification of PML by the sentrin family of ubiquitin-like proteins. J Biol Chem 273:3117-3120 (Pubitemid 28109713)
38. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ et al (1998) Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 339:1341-1348 (Pubitemid 28509343)
39. Zhu J, Lallemand-Breitenbach V, de The H (2001) Pathways of retinoic acid- or arsenic trioxide-induced PML/RARalpha catabolism, role of oncogene degradation in disease remission. Oncogene 20:7257-7265 (Pubitemid 33107375)
40. Jeanne M, Lallemand-Breitenbach V, Ferhi O, Koken M, Le Bras M, Duffort S et al (2010) PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3. Cancer Cell 18:88-98
41. Lallemand-Breitenbach V, de The H (2010) PML nuclear bodies. Cold Spring Harb Perspect Biol 2:a000661
42. Aoto T, Saitoh N, Ichimura T, Niwa H, Nakao M (2006) Nuclear and chromatin reorganization in the MHC-Oct3/4 locus at developmental phases of embryonic stem cell differentiation. Dev Biol 298:354-367 (Pubitemid 44468059)
43. Flenghi L, Fagioli M, Tomassoni L, Pileri S, Gambacorta M, Pacini R et al (1995) Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia. Blood 85:1871-1880
44. Gambacorta M, Flenghi L, Fagioli M, Pileri S, Leoncini L, Bigerna B et al (1996) Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. Am J Pathol 149:2023-2035 (Pubitemid 26415220)
45. Terris B, Baldin V, Dubois S, Degott C, Flejou JF, Henin D et al (1995) PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res 55:1590-1597
46. Li W, Ferguson BJ, Khaled WT, Tevendale M, Stingl J, Poli V et al (2009) PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool. Proc Natl Acad Sci U S A 106 (12):4725-4730
47. Everett RD, Chelbi-Alix MK (2007) PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89:819-830 (Pubitemid 47008945)
48. Stadler M, Chelbi-Alix MK, Koken MH, Venturini L, Lee C, Saib A et al (1995) Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11:2565-2573 (Pubitemid 26023824)
49. Ferbeyre G, de Stanchina E, Querido E, Baptiste N, Prives C, Lowe SW (2000) PML is induced by oncogenic ras and promotes premature senescence. Genes Dev 14:2015-2027 (Pubitemid 30637352)
50. Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S et al (2000) PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406:207-210 (Pubitemid 30469006)
51. de Stanchina E, Querido E, Narita M, Davuluri RV, Pandolfi PP, Ferbeyre G et al (2004) PML is a direct p53 target that modulates p53 effector functions. Mol Cell 13:523-535 (Pubitemid 38299380)
52. Jiang WQ, Zhong ZH, Henson JD, Reddel RR (2007) Identification of candidate alternative lengthening of telomeres genes by methio-nine restriction and RNA interference. Oncogene 26:4635-4647 (Pubitemid 47067407)
53. Stagno D'Alcontres M, Mendez-Bermudez A, Foxon JL, Royle NJ, Salomoni P (2007) Lack of TRF2 in ALT cells causes PML-dependent p53 activation and loss of telomeric DNA. J Cell Biol 179:855-867 (Pubitemid 350223484)
54. Goldberg AD, Banaszynski LA, Noh KM, Lewis PW, Elsaesser SJ, Stadler S et al (2010) Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 140:678-691
55. Lewis PW, Elsaesser SJ, Noh KM, Stadler SC, Allis CD (2010) Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication- independent chromatin assembly at telo-meres. Proc Natl Acad Sci U S A 107:14075-14080
56. Seeler JS, Marchio A, Sitterlin D, Transy C, Dejean A (1998) Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc Natl Acad Sci U S A 95:7316-7321 (Pubitemid 28293249)
57. He D, Mu ZM, Le X, Hsieh JT, Pong RC, Chung LW et al (1997) Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells. Cancer Res 57:1868-1872 (Pubitemid 27209713)
58. Le XF, Yang P, Chang KS (1996) Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML. J Biol Chem 271:130-135 (Pubitemid 26026568)
59. Mu ZM, Le XF, Vallian S, Glassman AB, Chang KS (1997) Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. Carcinogenesis 18:2063-2069 (Pubitemid 28134730)
60. Le XF, Vallian S, Mu ZM, Hung MC, Chang KS (1998) Recombinant PML adenovirus suppresses growth and tumorige-nicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene 16:1839-1849 (Pubitemid 28197403)
61. Alcalay M, Tomassoni L, Colombo E, Stoldt S, Grignani F, Fagioli M et al (1998) The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol Cell Biol 18:1084-1093 (Pubitemid 28063443)
62. Campisi J, d'Adda di Fagagna F (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8:729-740 (Pubitemid 47312822)
63. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593-602 (Pubitemid 27152402)
64. Regad T, Bellodi C, Nicotera P, Salomoni P (2009) The tumor suppressor Pml regulates cell fate in the developing neocortex. Nat Neurosci 12:132-140
65. Bernardi R, Pandolfi PP (2003) Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene 22:9048-9057 (Pubitemid 38121705)
66. Takahashi Y, Lallemand-Breitenbach V, Zhu J, de The H (2004) PML nuclear bodies and apoptosis. Oncogene 23:2819-2824 (Pubitemid 38659528)
67. Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon-Cardo C, Pandolfi PP (2006) Identification of a tumour suppressor network opposing nuclear Akt function. Nature 441:523-527 (Pubitemid 44050155)
68. Wang ZG, Ruggero D, Ronchetti S, Zhong S, Gaboli M, Rivi R et al (1998) PML is essential for multiple apoptotic pathways. Nat Genet 20:266-272 (Pubitemid 28507671)
69. Quignon F, De Bels F, Koken M, Feunteun J, Ameisen JC, de The H (1998) PML induces a novel caspase-independent death process. Nat Genet 20:259-265 (Pubitemid 28507670)
70. Fogal V, Gostissa M, Sandy P, Zacchi P, Sternsdorf T, Jensen K et al (2000) Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J 19:6185-6195
71. Salomoni P, Khelifi AF (2006) Daxx: death or survival protein? Trends Cell Biol 16:97-104 (Pubitemid 43247405)
72. Khelifi AF, D'Alcontres MS, Salomoni P (2005) Daxx is required for stress-induced cell death and JNK activation. Cell Death Differ 12:724-733 (Pubitemid 40945980)
73. Gurrieri C, Capodieci P, Bernardi R, Scaglioni PP, Nafa K, Rush LJ et al (2004) Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J Natl Cancer Inst 96:269-279 (Pubitemid 38256272)
74. Lee HE, Jee CD, Kim MA, Lee HS, Lee YM, Lee BL et al (2007) Loss of promyelocytic leukemia protein in human gastric cancers. Cancer Lett 247:103-109 (Pubitemid 44959417)
75. Zhang P, Chin W, Chow LT, Chan AS, Yim AP, Leung SF et al (2000) Lack of expression for the suppressor PML in human small cell lung carcinoma. Int J Cancer 85:599-605 (Pubitemid 30080469)
76. Koken MH, Linares-Cruz G, Quignon F, Viron A, Chelbi-Alix MK, Sobczak-Thepot J et al (1995) The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10:1315-1324
77. Yoon GS, Yu E (2001) Overexpression of promyelocytic leukemia protein and alteration of PML nuclear bodies in early stage of hepatocarcinogenesis. J Korean Med Sci 16:433-438 (Pubitemid 33741342)
78. Gray PA, Fu H, Luo P, Zhao Q, Yu J, Ferrari A et al (2004) Mouse brain organization revealed through direct genome-scale TF expression analysis. Science 306:2255-2257 (Pubitemid 40024462)
79. Ito K, Bernardi R, Morotti A, Matsuoka S, Saglio G, Ikeda Y et al (2008) PML targeting eradicates quiescent leukaemia-initiating cells. Nature 453(7198):1072-1078 (Pubitemid 351871736)
80. Woulfe J, Gray D, Prichett-Pejic W, Munoz DG, Chretien M (2004) Intranuclear rodlets in the substantia nigra: interactions with marinesco bodies, ubiquitin, and promyelocytic leukemia protein. J Neuropathol Exp Neurol 63:1200-1207 (Pubitemid 39492025)
81. Woulfe JM, Prichett-Pejic W, Rippstein P, Munoz DG (2007) Promyelocytic leukaemia-immunoreactive neuronal intranuclear rodlets in the human brain. Neuropathol Appl Neurobiol 33:56-66 (Pubitemid 46090310)
82. Villagra NT, Navascues J, Casafont I, Val-Bernal JF, Lafarga M, Berciano MT (2006) The PML-nuclear inclusion of human supraoptic neurons: a new compartment with SUMO-1- and ubiquitin-proteasome-associated domains. Neurobiol Dis 21:181-193 (Pubitemid 41817317)
83. Villagra NT, Berciano J, Altable M, Navascues J, Casafont I, Lafarga M et al (2004) PML bodies in reactive sensory ganglion neurons of the Guillain-Barre syndrome. Neurobiol Dis 16:158-168 (Pubitemid 38569807)
84. Berube NG, Mangelsdorf M, Jagla M, Vanderluit J, Garrick D, Gibbons RJ et al (2005) The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis. J Clin Invest 115:258-267 (Pubitemid 40385468)
85. Ritchie K, Seah C, Moulin J, Isaac C, Dick F, Berube NG (2008) Loss of ATRX leads to chromosome cohesion and congression defects. J Cell Biol 180:315-324 (Pubitemid 351185918)
86. Berube NG, Healy J, Medina CF, Wu S, Hodgson T, Jagla M et al (2007) Patient mutations alter ATRX targeting to PML nuclear bodies. Eur J Hum Genet 16(2):192-201
87. Salomoni P (2009) Stemming out of a new PML era? Cell Death Differ 16:1083-1092
88. Milyavsky M, Gan OI, Trottier M, Komosa M, Tabach O, Notta F et al (2010) A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal. Cell Stem Cell 7:186-197
89. Schwamborn JC, Berezikov E, Knoblich JA (2009) The TRIM-NHL protein TRIM32 activates microRNAs and prevents self-renewal in mouse neural progenitors. Cell 136:913-925
90. Tuoc TC, Stoykova A (2008) Trim11 modulates the function of neurogenic transcription factor Pax6 through ubiquitin-proteosome system. Genes Dev 22:1972-1986 (Pubitemid 352008644)
91. Chai Y, Koppenhafer SL, Shoesmith SJ, Perez MK, Paulson HL (1999) Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum Mol Genet 8:673-682 (Pubitemid 29139983)
92. Kaytor MD, Duvick LA, Skinner PJ, Koob MD, Ranum LP, Orr HT (1999) Nuclear localization of the spinocerebellar ataxia type 7 protein, ataxin-7. Hum Mol Genet 8:1657-1664 (Pubitemid 29423874)
93. Klement IA, Skinner PJ, Kaytor MD, Yi H, Hersch SM, Clark HB et al (1998) Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95:41-53 (Pubitemid 28458023)
94. Takahashi J, Fujigasaki H, Iwabuchi K, Bruni AC, Uchihara T, El Hachimi KH et al (2003) PML nuclear bodies and neuronal intranuclear inclusion in polyglutamine diseases. Neurobiol Dis 13:230-237 (Pubitemid 36939187)
95. Takahashi J, Fujigasaki H, Zander C, El Hachimi KH, Stevanin G, Durr A et al (2002) Two populations of neuronal intranuclear inclusions in SCA7 differ in size and promyelocytic leukaemia protein content. Brain 125:1534-1543 (Pubitemid 34755168)
96. Yamada M, Sato T, Shimohata T, Hayashi S, Igarashi S, Tsuji S et al (2001) Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases. Am J Pathol 159:1785-1795 (Pubitemid 33062521)
97. Mackenzie IR, Baker M, West G, Woulfe J, Qadi N, Gass J et al (2006) A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain 129:853-867
98. Kumada S, Uchihara T, Hayashi M, Nakamura A, Kikuchi E, Mizutani T et al (2002) Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies. J Neuropathol Exp Neurol 61:984-991 (Pubitemid 35278720)
99. Imarisio S, Carmichael J, Korolchuk V, Chen CW, Saiki S, Rose C et al (2008) Huntington's disease: from pathology and genetics to potential therapies. Biochem J 412:191-209 (Pubitemid 351758226)
100. Scaglioni PP, Yung TM, Cai LF, Erdjument-Bromage H, Kaufman AJ, Singh B et al (2006) A CK2-dependent mechanism for degradation of the PML tumor suppressor. Cell 126:269-283 (Pubitemid 44092959)
101. Lallemand-Breitenbach V, Zhu J, Puvion F, Koken M, Honore N, Doubeikovsky A et al (2001) Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J Exp Med 193:1361-1371 (Pubitemid 32565965)
102. Zhang XW, Yan XJ, Zhou ZR, Yang FF, Wu ZY, Sun HB et al (2010) Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science 328:240-243
103. Lafarga M, Berciano MT, Pena E, Mayo I, Castano JG, Bohmann D et al (2002) Clastosome: a subtype of nuclear body enriched in 19S and 20S proteasomes, ubiquitin, and protein substrates of proteasome. Mol Biol Cell 13:2771-2782
104. Janer A, Martin E, Muriel MP, Latouche M, Fujigasaki H, Ruberg M et al (2006) PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins. J Cell Biol 174:65-76 (Pubitemid 43992897)
105. Qin Q, Inatome R, Hotta A, Kojima M, Yamamura H, Hirai H et al (2006) A novel GTPase, CRAG, mediates promyelocytic leukemia protein-associated nuclear body formation and degradation of expanded polyglutamine protein. J Cell Biol 172:497-504 (Pubitemid 43243871)
106. Nucifora FC Jr, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M et al (2001) Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291:2423-2428 (Pubitemid 32231807)
107. Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H et al (2000) The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A 97:6763-6768 (Pubitemid 30412788)
108. Hayashi T, Sasaki C, Iwai M, Sato K, Zhang WR, Warita H et al (2001) Induction of PML immunoreactivity in rat brain neurons after transient middle cerebral artery occlusion. Neurol Res 23:772-776 (Pubitemid 32952710)
109. Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C et al (1998) Role of PML in cell growth and the retinoic acid pathway. Science 279:1547-1551 (Pubitemid 28217080)
110. Wichterle H, Przedborski S (2010) What can pluripotent stem cells teach us about neurodegenerative diseases? Nat Neurosci 13:800-804
111. Pardal R, Ortega-Saenz P, Duran R, Lopez-Barneo J (2007) Glia-like stem cells sustain physiologic neurogenesis in the adult mammalian carotid body. Cell 131:364-377 (Pubitemid 47576136)
112. Zhu J, Zhou J, Peres L, Riaucoux F, Honore N, Kogan S et al (2005) A sumoylation site in PML/RARA is essential for leukemic transformation. Cancer Cell 7:143-153 (Pubitemid 40248340)